Fulcrum Therapeutics (FULC)
(Delayed Data from NSDQ)
$8.60 USD
+0.60 (7.50%)
Updated Jul 22, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.06 |
EPS Last Quarter | -0.43 |
Last EPS Surprise | 2.27% |
ABR | 1.44 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.24 |
Next Year | -1.71 |
EPS (TTM) | -1.60 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 80.00M | NA | 80.00M | 32.88M |
# of Estimates | 2 | NA | 2 | 1 |
High Estimate | 80.00M | NA | 80.00M | 32.88M |
Low Estimate | 80.00M | NA | 80.00M | 32.88M |
Year ago Sales | 0.88M | 0.76M | 2.81M | 80.00M |
Year over Year Growth Est. | 8,990.91% | NA | 2,752.05% | -58.90% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.06 | -0.45 | -1.24 | -1.71 |
# of Estimates | 6 | 5 | 7 | 6 |
Most Recent Consensus | -0.43 | -0.43 | -0.78 | -1.27 |
High Estimate | 0.74 | -0.41 | -0.60 | -1.08 |
Low Estimate | -0.46 | -0.48 | -1.88 | -2.20 |
Year ago EPS | -0.38 | -0.39 | -1.59 | -1.24 |
Year over Year Growth Est. | 84.21% | -15.38% | 22.01% | -37.29% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.06 | -0.45 | -1.24 | -1.71 |
7 Days Ago | -0.06 | -0.45 | -1.24 | -1.71 |
30 Days Ago | -0.06 | -0.45 | -1.24 | -1.71 |
60 Days Ago | -0.06 | -0.45 | -1.24 | -1.71 |
90 Days Ago | -0.44 | -0.45 | -1.76 | -1.74 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.06 | -0.45 | -1.24 | -1.71 |
Zacks Consensus Estimate | -0.06 | -0.45 | -1.24 | -1.71 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.43 | -0.40 | -0.39 | -0.38 | NA |
Estimate | -0.44 | -0.44 | -0.44 | -0.44 | NA |
Difference | 0.01 | 0.04 | 0.05 | 0.06 | 0.04 |
Surprise | 2.27% | 9.09% | 11.36% | 13.64% | 9.09% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more